The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups

• Status: Completed
• Trial end date: 2011-02-01
• Target enrollment: 0
• Participant gender: Male

Summary

The study is designed to answer the following questions:

1. Is there any difference between the compositions of the HDL cholesterol subpopulations of patients with hypogonadism and the healthy controls.

2. What is the effect of testosterone replacement therapy on the distributions of HDL subgroups.

3. Is there any difference between the effects of the two different testosteron replacement regiments

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gulhane School of Medicine
• Treatments: Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate

Criteria

Inclusion Criteria:

• Congenital hypogonadotrophic hypogonadism,

• Male sex

Exclusion Criteria:

• Previous history of androgen replacement,

• any chronic disorder